European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 61-66 , February 2007

Prevention of intrahepatic recurrence by adjuvant 131iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis

  • M. Tabone

      Affiliations

    • Gastroenterology Division, Ospedale Mauriziano Umberto I, Largo Turati 62, 10128 Torino, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 11 5082600/5082537; fax: +39 11 5082557/5082293.
    • ,
  • L. Vigano'

      Affiliations

    • Surgical Oncology, I.R.C.C. Candiolo, Turin, Italy
    • ,
  • A. Ferrero

      Affiliations

    • Surgical Oncology, I.R.C.C. Candiolo, Turin, Italy
    • ,
  • R. Pellerito

      Affiliations

    • Nuclear Medicine, Ospedale Mauriziano Umberto I, Turin, Italy
    • ,
  • P. Carbonatto

      Affiliations

    • Interventional Radiology, Ospedale Mauriziano Umberto I, Turin, Italy
    • ,
  • L. Capussotti

      Affiliations

    • Surgical Oncology, I.R.C.C. Candiolo, Turin, Italy

,Accepted 26 October 2006.

References 

  1. Tung-Ping Poon R, Tat Fan S, Oi-Ling Ng I, Lo C, Liu C-L, Wong J. Different risk factors and prognosis for early and slow intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507
  2. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and slow phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–207
  3. Lau WY, Leung TW, Ho SK, et al. Adiuvant intra-arterial iodine-131 labelled lipiodol for resectable hepatocellular carcinoma. A prospective randomised trial. Lancet. 1999;353:797–801
  4. Boucher E, Corbinais S, Rolland Y, et al. Adiuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology. 2003;38:1237–1241
  5. Capussotti L, Muratore A, Amisano M, Polastri R, Bouzari H, Massucco P. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival – a European single center experience. Eur J Surg Oncol. 2005;31:986–993
  6. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83:1219–1222
  7. Mion F, Grozel L, Boillot O, Paliard P, Berger F. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology. 1996;111:1587–1592
  8. Caroli-Bottino A, Nascimento CM, Basto S, et al. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers. Transplant Proc. 2005;37:2791–2792
  9. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  10. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the TNM classification does not have prognostic power. Hepatology. 1998;27:1572–1577
  11. Stroffolini T, Sagnelli E, Mele A, Craxi A, Almasio P. Italian hospitals collaborative group. The aetiology of chronic hepatitis in Italy; results from a multicentre national study. Dig liver Dis. 2004;36:829–833
  12. www.ministerosalute.it/trapianti/normativa/statistiche.jsp
  13. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: a western experience Hepatogastroenterology. 1998;45(Suppl. 3):1281–1287
  14. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:122–130
  15. Uchiyama K, Ueno M, Hama T, et al. Recurrence of primary hepatocellular carcinoma after hepatectomy – differences related to underlying hepatitis virus species. Hepatogastroentrology. 2005;52:591–595
  16. Heathcote JE. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology. 2004;127:S294–S302
  17. Tabone M, Vigano' L, Laudi C, Ferreo A, Pellerito R, Capussotti L. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?. Hepatology. 2005;41(6):1433
  18. Partensky C, Sassolas G, Henry L, Paliard P, Maddern GJ. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma. Arch Surg. 2000;135:1298–1300
  19. Salem R, Lewandowski R, Roberts C, et al. Use of Yttrium-90 glass microspheres (Therasphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol. 2004;15:335–345
  20. Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol. 2002;13:S223–S229
  21. Sundram F, Minh Chau TC, Onkuudai P, Bernal P, Padhy KA. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2004;31:250–257
  22. Lambert B, Bacher K, Defreyne L, et al. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med. 2005;46:60–66
  23. Kumar A, Srivastava DN, Bal C. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil. J Vasc Interv Radiol. 2006;17:157–161
  24. Kubo S, Nishiguchi S, Hirohashi K, et al. Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus related hepatocellular carcinoma. Ann Intern Med. 2001;134:963–967
  25. Shiratori Y, Shiina S, Teratani T, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med. 2003;138:299–306
  26. Mazzaferro V, Romito R, Colombo M. Prospective randomised trial on IFN-therapy for the secondary prevention of HCC recurrence after curative resection in HCV related cirrhosis. Preliminary report. J Hepatol. 2004;40(Suppl. 1):A94

PII: S0748-7983(06)00433-1

doi: 10.1016/j.ejso.2006.10.039

European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 61-66 , February 2007

Article Tools

* Image Usage & Resolution